StockTipsArenaBeta

BUY Sakar Healthcare Limited — ICICI Securities

BUYSakar Healthcare Limited
Sakar Healthcare share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)17 Sept 2026via Institutional / Brokerage Research

Entry₹1,129.55Inferred
Target₹1,310
Total upside +15.98%
Stop lossNot given
CMP₹975.551d ago
Active-13.63%+34.28%upside left 10 mo left
Follow ICICI Securities for new calls(64% target hit, 1085 closed calls)Get alertsWatch SAKAR for new buy/sell callsGet alertsSee 1 other Long-term call on SAKARSee 542 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:27 pm IST
6 supporting2 neutral0 opposing
Supports the BUY call (6)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·30 Oct · 1w ago

Sakar Healthcare reported strong Q2 FY27 results with revenue up 53% YoY and EBITDA up 114% YoY, driven by oncology product growth and new regulatory approvals.

NSE · Press Release·26 Oct · 2w ago

(opens in new tab)

Multibagger stock rises 4.5% after Q2 results 2026 — Up 500% in 5 years; will rally continue? Experts' views, target, SL

NewsLivemint·26 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·23 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sakar Healthcare

All analyst calls on Sakar Healthcare

More from ICICI Securities

Every call and its outcome